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1 Glossary of Terms: Vision Screening 
Abnormal test result ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected under good conditions. The result on screening 
ĞƋƵŝƉŵĞŶƚŵĂǇŝŶĚŝĐĂƚĞ ?ŶŽƌĞƐƉŽŶƐĞ ? ? ?ĨĂŝů ? ?Žƌ ?ƌĞĨĞƌ  ?
Attendance rate The proportion of all those invited for screening that are tested 
and receive a result: 
 
x Invited for screening includes all those that are offered 
the screening test. 
x Tested and ƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƌĂů
ƚŽĚŝĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ?
 
Attendance rate provides information on the willingness of 
families to participate in screening. 
Compliance with 
referral (percentage) 
The percentage of those who are referred from screening to a 
diagnostic assessment that actually attend the diagnostic 
assessment. 
 
Percentage of compliance provides information on the 
willingness of families to attend the diagnostic assessment after 
referral from screening. 
Coverage The proportion of those eligible for screening that are tested and 
receive a result: 
 
x Eligible for screening includes those within the population 
that are covered under the screening or health care 
programme. 
x dĞƐƚĞĚĂŶĚƌĞĐĞŝǀĞĂƌĞƐƵůƚĐŽƵůĚďĞĂ ?ƉĂƐƐ ?Žƌ ?ƌĞĨĞƌƚŽ
diĂŐŶŽƐƚŝĐĂƐƐĞƐƐŵĞŶƚ ? ? 
 
Factors such as being offered screening, willingness to 
participate, missed screening, ability to complete the screen, and 
ability to document the screening results will influence the 
coverage. 
False negatives The percentage of children with a visual deficit (defined by the 
ƚĂƌŐĞƚĐŽŶĚŝƚŝŽŶ ?ƚŚĂƚƌĞĐĞŝǀĞĂƌĞƐƵůƚŽĨ ?ƉĂƐƐ ?ĚƵƌŝŶŐƐĐƌĞĞŶŝŶŐ ? 
 
Example: If 100 children with visual deficit are screened, and 1 
child passes the screening, the percentage of false negatives is 
1%. 
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False positives The percentage of children with normal vision that are referred 
from screening to a diagnostic assessment. 
Guidelines Recommendations or instructions provided by an authoritative 
body on the practice of screening in the country or region. 
Vision screening 
professional 
A person qualified to perform vision screening, according to the 
practice in the country or region. 
Inconclusive test 
result 
ƚĞƐƚƌĞƐƵůƚǁŚĞƌĞĂŶŽƌŵĂů ?ƉĂƐƐ ?ƌĞƐƉŽŶƐĞĐŽƵůĚŶŽƚďĞ
detected due to poor test conditions or poor cooperation of the 
child.  
Invited for screening Infants/children and their families who are offered screening. 
Outcome of vision 
screening 
An indication of the effectiveness or performance of screening, 
such as a measurement of coverage rate, referral rate, number of 
children detected, etc. 
Untreated amblyopia Those children who have not received treatment for amblyopia 
due to missed screening or missed follow-up appointment. 
Persistent amblyopia Amblyopia that is missed by screening, or present after the child 
has received treatment. 
Positive predictive 
value 
The percentage of children referred from screening who have a 
confirmed vision loss. 
 
For example, if 100 babies are referred from screening for 
diagnostic assessment and 10 have normal vision and 90 have a 
confirmed visual defect, the positive predictive value would be 
90%. 
Prevalence The percentage or number of individuals with a specific disease 
or condition. Prevalence can either be expressed as a percentage 
or as a number out of 1000 individuals within the same 
demographic. 
Programme An organised system for screening, which could be based 
nationally, regionally or locally. 
Protocol Documented procedure or sequence for screening, which could 
include which tests are performed, when tests are performed, 
procedures for passing and referring, and so forth. 
Quality assurance A method for checking and ensuring that screening is functioning 
adequately and meeting set goals and benchmarks. 
Referral criteria A pre-determined cut-off boundary for when a child should be 
re-tested or seen for a diagnostic assessment.  
Risk babies / Babies 
at-risk 
All infants that are considered to be at-risk or have risk-factors 
for vision defects/ophthalmic pathology according to the 
screening programme. 
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Two common risk factors are admission to the neonatal-intensive 
care unit (NICU) or born prematurely. However, other risk factors 
for visual defects may also be indicated in the screening 
programme. 
Sensitivity The percentage of children with visual defects that are identified 
via the screening programme. 
 
For example, if 100 babies with visual defects are tested, and 98 
of these babies are referred for diagnostic assessment and 2 pass 
the screening, the sensitivity is 98%. 
Specificity The percentage of children with normal vision that pass the 
screening. 
 
For example, if 100 babies with normal vision are tested, and 10 
of these babies are referred for diagnostic assessment and 90 
pass the screening, the specificity is 90%. 
Target condition The visual defect you are aiming to detect via the screening 
programme. 
Well, healthy babies Infants who are not admitted into the NICU or born prematurely 
(born after a gestation period of less than 37 weeks).  
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2 Abbreviations 
ACT  Alternating Cover Test 
AR  Autorefraction 
AS  Automated Screening 
CT  Cover Test 
CV  Colour Vision 
EI Eye Inspection 
EM  Eye Motility 
Fix  Fixation 
GDP  Gross Domestic Product 
GP General Practitioner 
Hir  Hirschberg test 
Kr  Danish Krone 
NICU Neonatal-intensive care unit 
PM Pursuit Movements 
PPP  Purchasing Power Parity 
PR  Pupillary Reflexes 
RE  Retinal Examination 
ROP Retinopathy of Prematurity 
RR  Red Reflex Testing 
SV  Stereopsis 
VA  Visual Acuity  
WHO  World Health Organisation 
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3 Population and Healthcare Overview 
The population of the Faroe Islands is estimated at 49,290 (World Bank, 2018a) and a birth 
rate estimated at 13.6 births/1,000 population in 2016 (World Bank, 2018b). The change in 
population and birth rate from 1960 to 2017 is shown in Figure 1, graphs A and B 
respectively. 
The Faroe Islands has an estimated population density of 35 people per square kilometre 
in 2017 and this has risen from 25 people per square kilometre in 1961 (World Bank, 
2018c).  
The average life expectancy in the Faroe Islands is estimated at 82 years (World Bank, 
2018d), with a death rate of 7.6 deaths/1,000 population in 2016 (World Bank, 2018e).  
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Figure 1: Total Population and Birth Rate in Faroe Islands 
 
Source: Information sourced from World Bank (2018) 
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4 Vision Screening Commissioning and Guidance 
Vision screening in the Faroe Islands has been implemented for at least forty years. It is 
organised nationally and is conducted in all areas, with no regional variation. The ministry 
of health, combined with expert advice from professionals, decide upon the content of the 
vision screening programme. The vision screening programme is funded by the state and is 
embedded into the general preventative child healthcare screening system.  
Vision screening is conducted by specialist nurses and general practitioners (GP). At 
present, there are 34 GPs and 31 specialist nurses that perform vision screening for the 
entire population. All GPs and specialist nurses carry out vision screening and the training is 
provided within the general training for the respective professions (GP, specialist nurse). 
There are nurses that do not screen, but could with additional training. Training is regularly 
updated, monitored and revalidated by the regulations for the health ministry in the Faroe 
Islands, however, the vision screening training provided is not accredited or certified as it is 
part of their general education.  
Vision screening takes place by the GP at their clinic. The specialist nurse performs vision 
screening at either the nurse centre, school, kindergarten or the homes of the families. 
Since its implementation, the vision screening programme has been changed to begin at 
earlier ages (in infants aged 9 months old), the timing of this change is not documented.  
It is unknown how often the vision screening programme is reviewed, but any revisions are 
decided by expert panels within the health ministry, and are funded by taxes. No methods 
for quality monitoring of vision screening are imposed by the government and there is no 
research or cost-effective analysis concerning the vision screening programme.  
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5 Screening programme  
The target conditions for preterm and healthy babies up to the age of 3 months are 
anatomical defects. The target conditions for children aged 3 months to 36 months, are 
strabismus and any condition affecting visual development. The target condition screened 
for by GPs and nurses in children aged 3 to 7 years of age is reduced visual acuity. If any 
child, no matter what age, has strabismus then they are referred for further diagnostic 
examination. If there is any doubt about the visual acuity of the child, they are referred. 
Vision screening is not repeated unless the child is not cooperating.  
The health care professionals delivering vision screening, venue for screening and tests used 
vary depending on the age of the child as shown in Tables 1, 2 and 3 respectively. Specific 
details of the screening offered within each age group are described more fully in sections 
5.1 to 5.4 below. 
5.1 Vision screening - Preterm babies 
Preterm babies born after 32 weeks with a normal weight are screened by a GP, and 
preterm babies born under 32 weeks or weighing <1500 grams, are screened at hospital by 
an ophthalmologist. The screening includes ophthalmoscopy and slitlamp examination. All 
the other babies are examined by the pediatrician when born. When the babies are ready to 
go home they  continue health screening, including vision screening, by the GP at the GP 
clinic. Eye inspection, fixation, red reflex testing and pursuit movements are performed on 
preterm babies up to the age of 3 months old.  
5.2 Vision screening - Birth to 3 months 
The vision screening tests conducted on well, healthy babies up to the age of 3 months 
include eye inspection, fixation, red reflex testing and pursuit movements. All of which are 
carried out at the hospital or GP clinic at 5 weeks of age by a GP or specialist nurse, with the 
exception of red reflex testing which is performed only by the GP. If there are problems with 
the reflex or anatomy of the eye, the child is referred to an ophthalmologist immediately.  
5.3 Vision screening - 3 months to 36 months 
The vision screening is performed five times between the age of 3 to 36 months; at 5 
months, 9 to 10 months, 1 year, 2 years and 3 years of age. At 5 months of age the GP will 
carry out an eye inspection, fixation, red reflex testing, pursuit movements and Hirschberg 
test. This is followed by fixation, pursuit movements and Hirschberg test repeated at 9 to 10 
months by a specialist nurse.  At 1, 2 and 3 years the GP performs an eye inspection, 
fixation, red reflex testing, pursuit movements and Hirschberg test. 
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5.4 Vision screening - 36 months to 7 years 
Vision screening is performed four times within this age group, conducted by the GP at ages 
3 to 4 and 4 to 5 years old, and then by a specialist nurse at 6 to 7 and 7 to 8 years old. The 
eye screening tests used within this age category are listed as Hirschberg, visual acuity, 
stereopsis (Stereo Fly Test) and colour vision testing.  
The visual acuity is tested using a Snellen or E chart (linear, crowded), ranging from 6/60 to 
6/3 Snellen (1.0 to -0.3 logMAR, 0.1 to 2.0 decimal). The type of chart used is determined by 
the professional performing the test, some GPs/specialist nurses have Snellen charts and 
others have E charts. The directions from the health ministery allow both type of charts to 
be used. After the age of 7-8 years testing is at variable intervals, ranging from 1 to 3 years 
between tests.  
Children are referred if the test is abnormal or inconclusive. If the vision test is abnormal, 
the children are referred to the ophthalmologist. If the vision test is inconclusive, the test is 
repeated within 1 month for children younger than 6 years, and within 1 to 3 months for 
older children.  
All children in this age range are referred if they have a visual acuity of less than 6/9 Snellen 
(0.2 logMAR, 0.67 decimal) in one or both eyes. All ages are referred if there is evidence of 
strabismus.  
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Table 1: Healthcare professionals who conduct vision screening in each age group  
Table 1.  Specialist nurse Ophthalmologist GP 
 
Paediatrician 
Preterm babies  
× 9 9 9 
0 to 3 months  9 × 9 × 
3 to 36 months  9 × 9 × 
3 to 7 years  9 × 9 × 
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Table 2: Vision screening tests used in vision screening for each age group  
Table 2. Hospital GP clinic Kindergarten School 
Preterm babies  9 9 × × 
0 to 3 months  9 9 × × 
3 to 36 months  
× 9 × × 
3 to 7 years  
× 9 9 9 
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Table 3: Location of vision screening for each age group  
Table 3.  
Eye 
inspection 
Fixation Red reflex Hirschberg 
Pursuit 
movements 
Visual acuity Stereopsis Colour vision 
Preterm 
babies  9 9 9 × 9 × × × 
0 to 3 
months  9 9 9 × 9 × × × 
3 to 36 
months  9 9 9 9 9 × × × 
3 to 7 years  
× × × 9 × 9 9 9 
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6 Automated Screening 
Automated vision screening is achieved using handheld, portable devices designed to detect 
presence of refractive error in infants from 6 months of age. It provides objective results 
and is used to detect amblyopic risk factors. This differs from other methods used to screen 
children for amblyopia which focus on detection of the actual condition and the resulting 
visual loss. No automated vision screening is used in the Faroe Islands.  
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7 Provision for Visually Impaired  
There are no schools in the Faroe Islands for blind or severely visually impaired children. 
Mainstream schools provide aids, tools and extra help from the teacher for these children. 
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8 Diagnostic Outcomes 
In the Faroe Islands, a specialist nurse has compiled a report for schoolchildren from the 
academic year 2016/2017  ? it is not clear if this is national or regional data. However, based 
on this report, the prevalence, coverage, treatment success and evaluation of screening 
have been estimated; these are detailed in section 8.1 to 8.4. 
8.1 Prevalence/Diagnosis  
The prevalence of treated or untreated amblyopia, by age 7, is estimated at 2.1%. There is 
no information on the prevalence of persistent amblyopia (missed by screening or failed 
treatment), or strabismus by age 7. The incidence (observed cases) of the four types of 
amblyopia are 1.2% for deprivation amblyopia, 0.3% for strabismic amblyopia, 1.0% for 
refractive amblyopia and 0.3% for combined mechanism amblyopia. The estimated 
distribution of amblyopia cases seen is, strabismic amblyopia 10%, refractive amblyopia 
36%, combined-mechanism amblyopia 10% and deprivation amblyopia 44%.  
Retinoblastoma and glaucoma are reported as being very rare in the Faroe Islands, with 1 or 
2 cases of infant cataract per year. There are a few other cases of congenital eye disorders 
per year, but no specific data are available.  
8.2 Coverage 
All children are invited for vision screening and almost 100% of these children attend for all 
ages of vision screening up to the age of 7 years old. Based on the 2016 to 2017 report, 
6,329 children underwent a health examination (which includes vision screening) out of 
7,146 possible school children. Therefore, 73 % of the schoolchildren were examined in 
2016/2017. 
8.3 Screening evaluation 
The percentage of false negatives is unknown, however, it is stated that this is seen some 
times and a rough estimate of 1 out of 50 children are given a pass at screening (i.e. 2%). 
The percentage of false positives in described as a more common occurrence, again without 
any specific percentages, a rough estimate of 1 out of 10 children screened. The positive 
predictive value (PPV) of a refer result, after vision screening is estimated at 80%. However, 
the sensitivity and specificity of vision screening is the Faroe Islands is unknown.  
8.4 Treatment success 
There is no data regarding the percentage of children treated for strabismus after screening 
before the age of 7. There is no information on the percentage of compliance with referral 
after an abnormal screening results. No data is available concerning how many patients are 
treated for congenital cataract, amblyopia or strabismus per year. Subsequent to referral 
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from vision screening, ophthalmologists prescribe glasses and/or patches for children up to 
the age of 7 years. All eligible children with vision disorders are offered treatment. 
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9 Costs of vision screening in children 
No specific data is available on the specific costs of vision screening in the Faroe Islands. All 
screening costs are facilitated through the tax system and free of charge to parents.  
9.1 Cost of vision screening  
The salary for a GP varies and is dependent upon how many patients the GP serves and how 
much the GP works. For vision screening, the GP receives 140 Danish Krones (Kr.) which is 
approximately 18.75 Euros* plus his/her normal salary. The total salary for a year is around 
600,000 to 1,200,000 kr. (80,400 to 160,800 Euros*). The specialist nurse has a salary 
between 324,000-384,000 kr. (43,400 to 51,500 Euros*) per year.  
9.2 Cost of treatment for amblyopia 
The costs for treatment of typical patients, with refractive amblyopia and strabismus 
amblyopia, including follow up are covered by taxes. The specific costs of this are not 
available. The parents are required to pay for any glasses or patches that might be required, 
but they get partly refunded by the health insurance providers. The number of follow-ups is 
dependent upon the age and severity of impairment.  
9.3 Cost of Treatment for strabismus  
Strabismus surgery, including follow-up, are covered by taxes, the specific costs of this are 
not available. However, glasses and patches are paid for, in part, by the parents.  
9.4 Cost of treatment for cataract 
The estimated costs for congenital cataract surgery, glasses, patching and follow-up of 
deprivation amblyopia are not available.  
 
 
 
 
 
 
 
* Currency conversion to Euros taken on 5/12/18  
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